The effect of retinoic acid on chemosensitivity of PA‐1 human teratocarcinoma cells and its modulation by an activated N‐ras oncogene
- 19 June 1992
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 51 (4) , 646-651
- https://doi.org/10.1002/ijc.2910510423
Abstract
Combination of chemotherapeutic drugs with agents that induce cell differentiation is a possible means of improving cancer chemotherapy. To explore this approach we used 4 cell lines established from the human teratocarcinoma‐derived cell line PA‐1; 2 retinoic acid (RA)‐sensitive lines compared to 2 RA‐resistant lines transformed by an activated N‐ras oncogene. Equal numbers of colony‐forming cells were exposed for 72 hr to 10−6M RA and subsequently to a range of concentrations of cisplatinum, etoposide or bleomycin. Enhanced cytotoxicity of cisplatin and etoposide (3‐ to 5‐fold) was observed in the N‐ras‐transformed cell lines compared to the non‐transformed lines. Treatment with RA caused an increase in the cytotoxicity of all 3 drugs to the 2 RA‐sensitive cell lines. In contrast, a reduction of cytotoxicity was observed in the 2 N‐ras‐transformed lines. Our results indicate that sensitivity to cytotoxic agents can be increased by RA in RA‐sensitive cells, but the opposite effect is seen in N‐ras transformed, RA‐resistant cells. Therefore, a general rationale for combination therapy with RA and cytotoxic drugs cannot be inferred.Keywords
This publication has 21 references indexed in Scilit:
- Phase II Study of 13-cis-Retinoic Acid in Pediatric Patients with Acute Nonlymphocytic Leukemia—A Pediatric Oncology Group StudyJournal of Immunotherapy, 1991
- Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoidsJournal of the American Academy of Dermatology, 1991
- Treatment of myelodysplastic syndromes with retinoic acid and 1α‐hydroxy‐vitamin D3 in combination with low‐dose ara‐C is not superior to ara‐C alone. Results from a randomized studyEuropean Journal of Haematology, 1990
- Differential oncogene amplification in tumor cells from a patient treated with cisplatin and 5-fluorouracilEuropean Journal of Cancer and Clinical Oncology, 1990
- Inhibition of growth and squamous‐cell differentiation markers in cultured human head and neck squamous carcinoma cells by β‐all‐trans retinoic acidInternational Journal of Cancer, 1990
- Altered accumulations of fibronectin are not dependent on fibronectin modifications during the differentiation of F-9 teratocarcinoma stem cellsExperimental Cell Research, 1988
- Pluripotent differentiation of single F9 embryonal carcinoma cellsExperimental Cell Research, 1987
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986
- An Activated ras N Gene: Detected in Late But Not Early Passage Human PA1 Teratocarcinoma CellsScience, 1984